Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs Nutanix Inc (NTNX) Price & Performance

Elanco Animal Health Incorporated Common StockTrade
Nutanix IncTrade

Price performance (Past 24H)

Key statistics

Elanco Animal Health Incorporated Common Stock vs Nutanix Inc — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.88 (market cap $11.26B), while Nutanix Inc trades at $74.06 (market cap $19.78B). The key difference: Nutanix Inc is the larger of the two by market cap, and Nutanix Inc is trading nearer its 52-week high, Elanco Animal Health Incorporated Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and Nutanix Inc for 17 Days on average.

ELANNTNX
Market Cap
$11.26B$19.78B
Volume
4,570,3861,717,619
Sector
HealthTechnology
52-Week High
$26.84$73.42
52-Week Low
$19.76$34.41
Typical Hold Time
0 Days17 Days
Enterprise Value
$14.65B$18.94B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Elanco Animal Health Incorporated Common Stock

No Aura AI signal available yet.

Nutanix Inc

Nutanix (NTNX) trades at $73.24, down slightly by 0.25% today, but maintains a bullish technical outlook with strong analyst support. The company demonstrates robust fundamentals with consistent earnings beats, including Q2 2026 EPS of $0.60 beating expectations of $0.49, and impressive profitability with an 86.8% gross margin. Recent Gartner Magic Quadrant recognitions highlight competitive strength in virtualization and container management platforms, supporting positive market sentiment.

The investment outlook remains positive with a consensus price target of $76.11 representing 4% upside potential. Key opportunities include external storage partnerships and AI growth initiatives, while risks involve high valuation multiples (EV/EBITDA of 46.22) and negative ROE of -395.76%. Institutional ownership trends and 62.5% analyst buy ratings suggest continued Wall Street confidence in the company's execution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ELAN
100% Buy0% Sell
Avg holding period · 0 Days
NTNX

No sentiment data available yet.

About Elanco Animal Health Incorporated Common Stock

Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.

Read more on ELAN →

About Nutanix Inc

Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.

Read more on NTNX →